Stockreport

Gilead Sciences: Debt Fueled Bottom [Seeking Alpha]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF SummaryGilead Sciences paid a hefty premium for Immunomedics.The breast cancer drug deal is expected to be accretive to EPS by 2023.The market wasn't fond hearing of the [Read more]